InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Explore the complete record of transactions filed by Harmon Cyrus, Chief Technology Officer. Officer active across 1 companies, notably Olema Pharmaceuticals, Inc.. In total, 12 disclosures have been published. Total volume traded: €2.1m. The latest transaction was disclosed on 29 November 2021 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
€8,770400 shares@ €21.92470.0007% mcap0.8% of flow
Common Stock
SEC:0001415889-21-005622·
€8,770400 shares@ €21.92470.0007% mcap0.4% of flow
Common Stock
SEC:0001415889-21-005622:0·
€178,2537,445 shares@ €23.94260.015% mcap16.6% of flow
Common Stock
SEC:0001415889-21-004934·
€178,2537,445 shares@ €23.94260.015% mcap8.3% of flow
Common Stock
SEC:0001415889-21-004934:0·
€269,04912,000 shares@ €22.42080.023% mcap25.1% of flow
Common Stock
SEC:0001415889-21-004513·
€269,04912,000 shares@ €22.42080.023% mcap12.5% of flow
Common Stock
SEC:0001415889-21-004513:0·
€256,61612,000 shares@ €21.38470.022% mcap23.9% of flow
Common Stock
SEC:0001415889-21-004029·
€256,61612,000 shares@ €21.38470.022% mcap12.0% of flow
Common Stock
SEC:0001415889-21-004029:0·
€165,8377,877 shares@ €21.05340.014% mcap15.5% of flow
Common Stock
SEC:0001415889-21-003664·
€165,8377,877 shares@ €21.05340.014% mcap7.7% of flow
Common Stock
SEC:0001415889-21-003664:0·
€193,8339,410 shares@ €20.59860.016% mcap18.1% of flow
Common Stock
SEC:0001415889-21-003129·
€193,8339,410 shares@ €20.59860.016% mcap9.0% of flow
Common Stock
SEC:0001415889-21-003129:0·
12 of 12 declarations
About Harmon Cyrus
Cyrus Harmon is the Chief Technology Officer (CTO) of Olema Pharmaceuticals, Inc. In this role, he is responsible for leading the company's technology initiatives. His expertise in technology and innovation is crucial for the development of new products and solutions. He plays a key role in the strategic direction of Olema Pharmaceuticals, Inc.
